Cargando…

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy

This retrospective study evaluated the expression of β1 integrins and associated proteins as prognostic markers for primary radio(chemo)therapy outcome of patients with locally advanced head and neck squamous cell carcinomas (HNSCC). Tissue microarrays were prepared from 224 HNSCC patients undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordes, Nils, Ney, Michael, Beleites, Thomas, Aust, Daniela, Baretton, Gustavo, Thames, Howard, Baumann, Michael, Krause, Mechthild, Löck, Steffen, Appold, Steffen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301664/ https://www.ncbi.nlm.nih.gov/pubmed/30571736 http://dx.doi.org/10.1371/journal.pone.0209479

Ejemplares similares

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
por: Zschaeck, Sebastian, et al.
Publicado: (2016)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
por: Starke, Sebastian, et al.
Publicado: (2023)

Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors
por: Rassamegevanon, Treewut, et al.
Publicado: (2018)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy
por: Jakobi, Annika, et al.
Publicado: (2015)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
por: Bandurska-Luque, Anna, et al.
Publicado: (2019)

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
por: Gommlich, A., et al.
Publicado: (2021)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
por: Bütof, Rebecca, et al.
Publicado: (2017)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Salivary IgA as a Surrogate Biomarker for Microbial Infections in Postoperative Patients Receiving Chemo-Radio-Therapy for Head and Neck Cancer
por: Chavan, Preeti, et al.
Publicado: (2023)

Stent patency in patients with distal malignant biliary obstruction receiving chemo(radio)therapy
por: Haal, Sylke, et al.
Publicado: (2017)

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
por: Wiltgen, Tun, et al.
Publicado: (2022)

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy
por: Raschke, F., et al.
Publicado: (2022)

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial
por: Bütof, R., et al.
Publicado: (2017)

Concept for individualized patient allocation: ReCompare—remote comparison of particle and photon treatment plans
por: Lühr, Armin, et al.
Publicado: (2014)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

PO-0951 Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients
por: Bandurska-Luque, A., et al.
Publicado: (2021)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

MR perfusion measurements on pharyngeal tumors: Comparison of quantification strategies
por: Hietschold, Volker, et al.
Publicado: (2004)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
por: Zscheppang, Katja, et al.
Publicado: (2016)

Focal Adhesion-Chromatin Linkage Controls Tumor Cell Resistance to Radio- and Chemotherapy
por: Storch, Katja, et al.
Publicado: (2012)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

Radio receiver design /
por: Dixon, Robert Clyde, 1932-
Publicado: (1998)

Radio receiver design
por: Sturley, K R
Publicado: (1953)

Radio receiver design
por: McClaning, Kevin, et al.
Publicado: (2000)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts
por: Yao, Wenhao, et al.
Publicado: (2021)

A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy
por: Bozzetti, Federico, et al.
Publicado: (2021)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
por: Cubillos-Mesías, Macarena, et al.
Publicado: (2017)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Fazel, Asita, et al.
Publicado: (2020)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
por: Hölscher, Tobias, et al.
Publicado: (2022)

Applying Tissue Slice Culture in Cancer Research—Insights from Preclinical Proton Radiotherapy
por: Suckert, Theresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_frqomnopptgs852dcfv08fuq2p